Mar 02, 2026
Non-Invasive 40Hz Transcranial Vibration for Enhanced Glymphatic Clearance: A Pilot Study
- Bushra Fatima1
- 1Al Nafees Medical College, Islamabad
- Bushra Fatima: Principal Investigator
Protocol Citation: Bushra Fatima 2026. Non-Invasive 40Hz Transcranial Vibration for Enhanced Glymphatic Clearance: A Pilot Study. protocols.io https://dx.doi.org/10.17504/protocols.io.14egn1rbzv5d/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: In development
Initial pilot study protocol developed for neuro-glymphatic research at Al Nafees Medical College. Currently in the optimization phase for device interface.
Created: March 01, 2026
Last Modified: March 02, 2026
Protocol Integer ID: 244227
Keywords: transcranial vibration, monitoring salivary cortisol, bilateral temporalis muscle, salivary cortisol, enhanced glymphatic clearance, sinusoidal mechanical vibration, metabolic waste clearance via the glymphatic system, heart rate variability, glymphatic system, neuroprotection
Disclaimer
This protocol is intended for research purposes only and describes an experimental pilot study. It is not a substitute for professional medical advice, diagnosis, or treatment. The 40Hz frequency parameters are based on current neuro-metabolic research and must be administered under clinical supervision.
Abstract
This pilot study investigates the efficacy of 40Hz sinusoidal mechanical vibration applied to the bilateral Temporalis muscles to facilitate neuro-metabolic waste clearance via the glymphatic system. By monitoring salivary cortisol and heart rate variability (HRV), this research seeks to establish a non-pharmacological protocol for neuroprotection and accelerated post-surgical recovery.
Guidelines
Safety Precautions: Participants with a history of epilepsy, recent head trauma, or metallic cranial implants are excluded. Stimulation is limited to 20 minutes to prevent over-stimulation. If vertigo occurs, cease stimulation immediately
Materials
- Custom 40Hz Piezoelectric Actuator Headband: Designed for focal contact with the bilateral Temporalis muscles.
- Programmable Signal Generator: Capable of maintaining a stable 40Hz sinusoidal output.
- Salivary Cortisol Collection Kits (ELISA): For pre- and post-intervention biochemical analysis.
- HRV Monitor: Clinical-grade wearable for real-time Heart Rate Variability tracking.
- Digital Visual Analogue Scale (VAS): For recording subjective "Brain Fog" and stress levels.
Troubleshooting
Safety warnings
Warnings / Contraindications
- Epilepsy Warning: This protocol involves rhythmic 40Hz mechanical stimulation. It is strictly contraindicated for individuals with a history of generalized or focal epilepsy, as it may lower the seizure threshold.
- Cranial Integrity: Do not apply stimulation to individuals with recent head trauma, unhealed skull fractures, or those with implanted medical devices (e.g., Vagus Nerve Stimulators, DBS, or metallic plates).
- Vertebrobasilar Insufficiency: If the participant experiences sudden vertigo, nausea, or nystagmus during the 40Hz application, the procedure must be terminated immediately.
- Acoustic Sensitivity: Users with severe hyperacusis should use ear protection, as the mechanical vibration of the temporal bone may be perceived as an audible hum.
Ethics statement
Safety, Ethical Compliance, and Participant Protection
I. Ethical Oversight and Consent This protocol is currently presented as a theoretical and methodological framework for neuro-metabolic research. The author acknowledges that any future clinical implementation, including the recruitment of human subjects, is strictly contingent upon:
- Institutional Review: Formal submission to and written approval by the Institutional Review Board (IRB) or the Ethics Review Committee (ERC) at Al Nafees Medical College / Isra University.
- Informed Consent: Adherence to the Declaration of Helsinki, ensuring all participants provide voluntary, written informed consent prior to any intervention.
II. Clinical Safety Parameters To ensure participant safety during 40Hz mechanical stimulation, the following exclusionary criteria and precautions are established:
- Seizure Prophylaxis: Individuals with a history of photosensitive or mechanosensitive epilepsy are excluded from this protocol to prevent cortical over-excitation.
- Hardware Constraints: Participants with metallic cranial implants, shunts, or pacemakers are excluded to avoid mechanical interference.
- Frequency Stability: The delivery system must be calibrated to maintain a stable 40Hz oscillation with a sub-traumatic amplitude to prevent dural irritation or bone fatigue.
III. Researcher Accountability The Principal Investigator (PI) remains responsible for monitoring participant well-being and ensuring that the focal vibration does not exceed established comfort or safety thresholds.
Neuro-Glymphatic Stimulation Protocol
Device placement on Temporalis muscles.
40Hz vibration for 20 minutes.
Morning and Night timing.
Protocol references
1. The Primary Reference (The "Vibration" Proof)
This is your most important citation because it specifically mentions Vibration (TVS) in humans to improve brain fluid flow.
Kong L, Jin W, Jiang Y, Yan F, Liu J, Leuthardt EC, et al. Transcranial vibration stimulation at 40 Hz induced neural activity and promoted the coupling of global brain activity and cerebrospinal fluid flow. NeuroImage. 2025 Feb 15;308:121074. doi: 10.1016/j.neuroimage.2024.121074.
2. The MIT Glymphatic Discovery (The "Why")
This 2024 paper from Li-Huei Tsai's lab at MIT proves that 40Hz clears waste through the "pipes" of the brain.
Murdock MH, Yang CY, Sun N, Tsai LH, et al. Multisensory gamma stimulation promotes glymphatic clearance of amyloid. Nature. 2024 Feb 28;627(8002):149-156. doi: 10.1038/s41586-024-07132-z.
3. The Human Pilot Study (The "Safety")
This shows that 40Hz is safe and works in human Alzheimer's patients.
Chan D, Suk HJ, Jackson BL, Milman NP, Stark D, Klerman EB, et al. Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies. PLoS ONE. 2022 Dec 1;17(12):e0278412. doi: 10.1371/journal.pone.0278412.